Pasar al contenido principal

ANALISIS SISTEMATICO DE LA REGULACION POSTRADUCCIONAL DE LA ACTIVACION DEL GENOMA CIGOTICO EN VERTEBRADOS: UNA APROXIMACION CRISPR-CAS13D

PID2021-127535NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD PABLO DE OLAVIDE, DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice

  • Böck, Desirée
  • Revers, Ilma M.
  • Bomhof, Anastasia S.J.
  • Hillen, Anne E.J.
  • Boeijink, Claire
  • Kissling, Lucas
  • Egli, Sabina
  • Moreno-Mateos, Miguel A.
  • Knaap, Marjo S. van der
  • Til, Niek P. van
  • Schwank, Gerald
Vanishing white matter (VWM) is a fatal leukodystrophy caused by recessive mutations in subunits of the eukaryotic translation initiation factor 2B. Currently, there are no effective therapies for VWM. Here, we assessed the potential of adenine base editing to correct human pathogenic VWM variants in mouse models. Using adeno-associated viral vectors, we delivered intein-split adenine base editors into the cerebral ventricles of newborn VWM mice, resulting in 45.9% ± 5.9% correction of the Eif2b5R191H variant in the cortex. Treatment slightly increased mature astrocyte populations and partially recovered the integrated stress response (ISR) in female VWM animals. This led to notable improvements in bodyweight and grip strength in females; however, locomotor disabilities were not rescued. Further molecular analyses suggest that more precise editing (i.e., lower rates of bystander editing) as well as more efficient delivery of the base editors to deep brain regions and oligodendrocytes would have been required for a broader phenotypic rescue. Our study emphasizes the potential, but also identifies limitations, of current in vivo base-editing approaches for the treatment of VWM or other leukodystrophies., This work was supported by the Swiss National Science Foundation (SNSF) grant no. 310030_185293 (to G.S.), Novartis Foundation for Medical-Biological Research no. FN20-0000000203 (to D.B.), SNSF Spark fellowship no. 196287 (to D.B.), and the Helmut Horten Foundation F-41603-14-01 (to G.S.). M.S.v.d.K. is a member of the European Reference Network for Rare Neurological Disorders (ERNRND), project ID 739510 . Work in the lab of M.A.M.-M. was supported by grants PID2021-127535NB-I00 , CEX2020-001088-M , RyC-2017-23041, and UPO1380590 funded by MCIN/AEI/10.13039/501100011033, by “ERDF A way of making Europe” and “ERDF A way of making Europe,” University Pablo de Olavide and Junta de Andalucía, respectively., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001088-M)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ribonucleotide reductase inhibition improves the symptoms of a Caenorhabditis elegans model of Alzheimer’s disease

  • Brokate-Llanos, Ana María
  • Sanchez-Ibañez, Mireya
  • Pérez-Jiménez, Mercedes M.
  • Monje-Moreno, José Manuel
  • Gómez-Marín, Carlos
  • Caro, Carlos
  • Vivar-Rios, Carlos
  • Moreno-Mateos, Miguel A.
  • García-Martín, María Luisa
  • Muñoz-Ruiz, Manuel Jesús
  • Royo, José Luis
Alzheimer's disease is the main cause of aging-associated dementia, for which there is no effective treatment. In this work, we reanalyze the information of a previous genome wide association study, using a new pipeline design to identify novel potential drugs. With this approach, ribonucleoside-diphosphate reductase gene (RRM2B) emerged as a candidate target and its inhibitor, 2′, 2′-difluoro 2′deoxycytidine (gemcitabine), as a potential pharmaceutical drug against Alzheimer's disease. We functionally verified the effect of inhibiting the RRM2B homolog, rnr-2, in an Alzheimer's model of Caenorhabditis elegans, which accumulates human Aβ1-42 peptide to an irreversible paralysis. RNA interference against rnr-2 and also treatment with 200 ng/ml of gemcitabine, showed an improvement of the phenotype. Gemcitabine treatment increased the intracellular ATP level 3.03 times, which may point to its mechanism of action. Gemcitabine has been extensively used in humans for cancer treatment but at higher concentrations. The 200 ng/ml concentration did not exert a significant effect over cell cycle, or affected cell viability when assayed in the microglia N13 cell line. Thus, the inhibitory drug of the RRM2B activity could be of potential use to treat Alzheimer's disease and particularly gemcitabine might be considered as a promising candidate to be repurposed for its treatment., MMPJ was granted with Fondo Europeo de Desarrollo Regional (FEDER) and the “Consejería de Universidad, Ciencia, Innovación y Universidades, Junta de Andalucía” Project UPO-1266266. JLR was granted with the project UMA20-FEDERJA-133 and MJM by the Ministerio de Ciencia, Innovación y Universidades grant PID2020-120463RB-I00. Work in MAM-M was supported by grants PID2021-127535NB-I00, CEX2020-001088-M and RyC-2017-23041 funded by Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Innovación/10.13039/501100011033 by “ERDF A way of making Europe” and by ESF Investing in your future, grant UPO1380590 funded by “ERDF A way of making Europe,” Universidad Pablo de Olavide, and Junta de Andalucía. CGM was funded with ayudas captacion, incorporación y movilidad de capital humano de I+D+i, Junta de Andalucía. POSTDOC 21_00667. The C. elegans assy unit of the University Pablo de Olavide funded part of the work., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001088-M)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comparing robotic and manual injection methods in zebrafish embryos for high-throughput RNA silencing using CRISPR-RfxCas13d

  • Abugattas-Nuñez del Prado, Joaquin A.
  • Ding, Yi
  • Sonneville, Jan de
  • Kolk, Kees-Jan van der
  • Moreno-Mateos, Miguel A.
  • Málaga-Trillo, Edward
  • Spaink, Herman P.
© 2024 The Authors., In this study, the authors compared the efficiency of automated robotic and manual injection methods for the CRISPR-RfxCas13d (CasRx) system for mRNA knockdown and Cas9-mediated DNA targeting in zebrafish embryos. They targeted the no tail (TBXTA) gene as a proof-of-principle, evaluating the induced embryonic phenotypes. Both Cas9 and CasRx systems caused loss of function phenotypes for TBXTA. Cas9 protein exhibited a higher percentage of severe phenotypes compared with mRNA, while CasRx protein and mRNA showed similar efficiency. Both robotic and manual injections demonstrated comparable phenotype percentages and mortality rates. The findings highlight the potential of RNA-targeting CRISPR effectors for precise gene knockdown and endorse automated microinjection at a speed of 1.0 s per embryo as a high-throughput alternative to manual methods., Work in MA Moreno-Mateos' lab was supported by grants PID2021-127535NB-I00, CEX2020-001088-M and RyC-2017-23041 funded by MCIN/AEI/ 10.13039/501100011033 by “ERDF A way of making Europe” and by ESF Investing in your future, grant UPO1380590 funded by “ERDF A way of making Europe”, University Pablo de Olavide and Junta de Andalucía., With funding from the Spanish government through the ‘María de Maeztu Unit of Excelence’ accreditation (CEX2020-001088-M), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish

  • Moreno-Sánchez, Ismael
  • Hernández-Huertas, Luis
  • Nahón-Cano, Daniel
  • Martínez-García, Pedro Manuel
  • Treichel, Anthony J.
  • Gómez-Marín, Carlos
  • Tomás-Gallardo, Laura
  • Silva Pescador, Gabriel da
  • Kushawah, Gopal
  • Egidy, Rhonda
  • Perera, Anoja
  • Díaz Moscoso, Alejandro
  • Cano-Ruiz, Alejandra
  • Walker, John A.
  • Muñoz-Ruiz, Manuel Jesús
  • Holden, Kevin
  • Galcerán, Joan
  • Nieto, M. Ángela
  • Bazzini, Ariel A.
  • Moreno Mateos, Miguel Ángel
CRISPR-Cas13 RNA-targeting systems are widely used in basic and applied sciences. However, its application has recently generated controversy due to collateral activity in mammalian cells and mouse models. Moreover, its competence could be improved in vivo. Here, we optimized transient formulations as ribonucleoprotein complexes or mRNA-gRNA combinations to enhance the CRISPR-RfxCas13d system in zebrafish. We i) use chemically modified gRNAs to allow more penetrant loss-of-function phenotypes, ii) improve nuclear RNA targeting, and iii) compare different computational models and determine the most accurate to predict gRNA activity in vivo. Furthermore, we demonstrate that transient CRISPR-RfxCas13d can effectively deplete endogenous mRNAs in zebrafish embryos without inducing collateral effects, except when targeting extremely abundant and ectopic RNAs. Finally, we implement alternative RNA-targeting CRISPR-Cas systems such as CRISPR-Cas7-11 and CRISPR-DjCas13d. Altogether, these findings contribute to CRISPR-Cas technology optimization for RNA targeting in zebrafish through transient approaches and assist in the progression of in vivo applications., We thank all members of the Moreno-Mateos laboratory for their intellectual and technical support. This work was supported by Ramon y Cajal (RyC-2017-23041), PID2021-127535NB-I00, CNS2022-135564 and CEX2020-001088-M grants funded by MICIU/AEI/ 10.13039/501100011033 by “ERDF A way of making Europe” (“ERDF/EU”), and by ESF Investing in your future from Ministerio de Ciencia, Innovación y Universidades and European Union (M.A.M.-M.). This work has also been co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU (PRTR-C17.I1) and the Regional Ministry of University, Research, and Innovation of the Autonomous Community of Andalusia within the framework of the Biotechnology Plan applied to Health. The Moreno-Mateos lab was also funded by the European Regional Development Fund (FEDER 80% of the total funding) by the Ministry of Economy, Knowledge, Business and University, of the Government of Andalusia, within the framework of the FEDER Andalusia 2014-2020 operational program within the objective “Promotion and generation of frontier knowledge and knowledge oriented to the challenges of society, development of emerging technologies (grant UPO-1380590)” and by the Fondo Europeo de Desarrollo Regional (FEDER) and Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía, within the operative program FEDER Andalucía 2014-2020 (01—Refuerzo de la investigación, el desarrollo tecnológico y la innovación, grant P20_00866). M.A.M.-M. was the recipient of the Genome Engineer Innovation 2019 Grant from Synthego. The CABD is an institution funded by University Pablo de Olavide, Consejo Superior de Investigaciones Científicas (CSIC), and Junta de Andalucía. I.M-S. was a recipient of the Margarita Salas Postdoctoral contract funded by “NextGenerationEU”, Plan de Recuperación, Transformación y Resilencia and Ministerio de Ciencia, Innovación y Universidades (recualificación del sistema universitario español 2021-2023, Pablo de Olavide University Call). L.H-H. and D.N-C. were recipients of Ayudas para contratos predoctorales para la formación de doctores (Ministerio de Ciencia e Innovación) funded by MICIU/AEI /10.13039/501100011033 and FSE invierte en tu futuro and FSE. C.G-M. was funded with Ayudas captación, incorporación y movilidad de capital humano de I+D+i, Junta de Andalucía (POSTDOC 21_00667). P.M.M.G. was funded by a postdoctoral fellowship from Junta de Andalucía (DOC_00397). This study was supported by the Stowers Institute for Medical Research. A.A.B. was awarded a US National Institutes of Health grant (NIH-R01 GM136849 and NIH R21OD034161). A.J.T. was supported by the US National Institute of Health: F31HD110268. This work was completed as part of thesis research for A.J.T. and G.dS.P., Graduate School of the Stowers Institute for Medical Research. This work was supported by grant PID2021-125682NB-I00 to M.A.N. funded by MICIU/AEI /10.13039/501100011033 and by FEDER, UE; funds were also provided by Instituto de Salud Carlos III (CIBERER, CB19/07/00038 to M.A.N.) and Generalitat Valenciana (Prometeo 2021/45). M.A.N. also acknowledges financial support from the Spanish State Research Agency, through the “Severo Ochoa Program” for Centres of Excellence in R&D Grant CEX2021-001165-S funded by MCIN/AEI/ 10.13039/501100011033. M.J.M. was supported by grant PID2020-120463RB-I00 funded by the Spanish Ministerio de Ciencia e Innovación. We thank our colleague Francisco J. Guerra (Stowers Institute and CABD) for the initial research on Cas7-11, Amanda Lawlor and Kate Hall (Stowers Institute) for their technical work on RNA sequencing, and Cielo Centola for the help with illustrations (CABD)., With funding from the Spanish government through the "María de Maeztu Unit of Excellence" accreditation (CEX2020-001088-M)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S)., Peer reviewed, Modelo experimental animal, Modelo experimental alternativo-NAM, Peces - Peces de agua dulce., Embriones no protegidos por la ley - Embriones de Peces. Danio, Orycias
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CRISPR-RfxCas13d screening uncovers Bckdk as a post-translational regulator of maternal-to-zygotic transition in teleosts

  • Hernández-Huertas, Luis
  • Moreno-Sánchez, Ismael
  • Crespo-Cuadrado, Jesús
  • Vargas-Baco, Ana
  • Pescador, Gabriel da Silva
  • Zhang, Ying
  • Wen, Zhihui
  • Florens, Laurence
  • Santos-Pereira, José M.
  • Bazzini, Ariel A.
  • Moreno-Mateos, Miguel A.
[Data availability] RNA-seq, ATAC-seq, CUT&RUN, and SLAM-seq data have been deposited in GEO under accession code GSE268294 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268294). Proteomics, phospho-proteomics, and isoleucine-leucine data have been deposited at MassIVE MSV000094733 Valine quantification data have been deposited at MassIVE MSV000094867. The source data of this paper are collected in the following database record: biostudies:S-SCDT-10_1038-S44318-025-00617-8., The maternal-to-zygotic transition (MZT) is a reprograming process encompassing zygotic genome activation (ZGA) and the clearance of maternally-provided mRNAs. While some factors regulating MZT have been identified, there are thousands of maternal RNAs whose function has not been ascribed yet. Here, we have performed a proof-of-principle CRISPR-RfxCas13d maternal screen, in which we targeted mRNAs encoding kinases and phosphatases or proteins regulating them in zebrafish. This screen identified branched-chain ketoacid dehydrogenase kinase, Bckdk, as a novel post-translational regulator of MZT. Bckdk mRNA knockdown caused epiboly defects, ZGA deregulation, H3K27ac reduction and a partial impairment of miR-430 processing. Phospho-proteomic analysis revealed that Phf10/Baf45a, a chromatin remodeling factor, is less phosphorylated upon Bckdk depletion. Further, phf10 mRNA knockdown also altered ZGA, and expression of a phospho-mimetic mutant of Phf10 rescued the developmental defects observed after bckdk mRNA depletion, as well as restored H3K27ac levels. Altogether, our results demonstrate the competence of CRISPR-RfxCas13d screenings to uncover new regulators of early vertebrate development and shed light on the post-translational control of MZT mediated by protein phosphorylation., We thank all members of the Moreno-Mateos and the Bazzini laboratories for their intellectual and technical support. This work was supported by Ramon y Cajal (RyC-2017-23041), PGC2018-097260-B-I00, PID2021-127535NB-I00, MDM-2016-0687, and CEX2020-001088-M grants funded by MICIU/AEI/10.13039/501100011033 by “ERDF A way of making Europe”, “ERDF/EU” and by ESF Investing in your future from Ministerio de Ciencia, Innovación y Universidades and European Union (MAM-M). MAM-M was the recipient of the Genome Engineer Innovation 2019 Grant from Synthego. The Moreno-Mateos lab has been also co-financed by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU (PRTR-C17.I1) and the Regional Ministry of University, Research and Innovation of the Autonomous Community of Andalusia within the framework of the Biotechnology Plan applied to Health, grant CNS2022-135564 funded by MICIU/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR, the European Regional Development Fund (FEDER 80% of the total funding) by the Ministry of Economy, Knowledge, Business and University, of the Government of Andalusia, within the framework of the FEDER Andalusia 2014-2020 operational program within the objective “Promotion and generation of frontier knowledge and knowledge oriented to the challenges of society, development of emerging technologies (grant UPO-1380590)” and by the Fondo Europeo de Desarrollo Regional (FEDER) and Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía, within the operative program FEDER Andalucía 2014-2020 (01—Refuerzo de la investigación, el desarrollo tecnológico y la innovación, grant P20_00866). The CABD is an institution funded by Pablo de Olavide University, Consejo Superior de Investigaciones Científicas (CSIC), and Junta de Andalucía. LH-H was a recipient of ayudas para contratos predoctorales para la formación de doctores contemplada en el Subprograma Estatal de Formación del Programa Estatal de Promoción del Talento y su Empleabilidad en I + D + i, en el marco del Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (Ministerio de Ciencia e Innovación). JC-C is supported by the Junta de Andalucía Predoctoral Grant (PREDOC_01569), respectively. IM-S was a recipient of the Margarita Salas Postdoctoral contract funded by “NextGenerationEU”, Plan de Recuperación, Transformación y Resilencia and Ministerio de Universidades (recualificación del sistema universitario español 2021-2023, Pablo de Olavide University Call). JMS-P was funded by an Emergia grant from Junta de Andalucía (EMC21_00188). This study was supported by the Stowers Institute for Medical Research. AAB was awarded a US National Institutes of Health grant (NIH-R01 GM136849 and NIH R21OD034161). This work was performed as part of thesis research for the GdSP, Graduate School of the Stowers Institute for Medical Research grants. We thank our colleagues Juan Ramon Martínez-Morales, Barbara Pernaute and Thomas Spruce (CABD, Seville, Spain), and Jose Carlos Reyes (CABIMER, Seville, Spain) for the critical reading of the manuscript. We also thanks Rhonda Egidy and Anoja Perera from Sequencing and Discovery Genomics facility at (Kansas, MO, USA), Danielson Baia Amaral (Stowers Institute) for technical support in performing injections, embryo collection, photography, and qPCR for Valine quantification experiments, applying Slamdunk pipeline and providing suggestions on the manuscript draft, Juan J. Tena, Thirsa Brethouwer and Cielo Centola (CABD, Seville, Spain) for H3K27ac antibody, and helping with CUT&RUN experiment and synopsis image, respectively., With funding form the Spanish government through the “María de Maeztu Unit of Excellence” accreditation (CEX2020-001088-M)., Peer reviewed